It is just a drug designed by Hoffmann-La Roche which acts as being a potent and selective unfavorable allosteric modulator for team II of the metabotropic glutamate receptors (mGluR2/three), becoming equipotent at mGluR2 and mGluR3 but without having activity at other mGluR subtypes.When the peak in the experience or sensation is achieved it may p